AEGiS-AP: Jesse Jackson calls for investigation into AIDS drug Associated PressImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu




DonateNow



Jesse Jackson calls for investigation into AIDS drug

Associated Press - December 17, 2004
Mike Colias, Associated Press Writer


CHICAGO (AP) - The Rev. Jesse Jackson called for a congressional investigation into reports that U.S. health officials withheld research from the White House that showed an AIDS drug distributed to hundreds of thousands of Africans posed serious risks.

He also said the U.S. government should immediately halt the drug's distribution in Africa.

"This was not a thoughtful and reasonable decision, but a crime against humanity," Jackson said Thursday. "Research standards and drug quality that are unacceptable in the U.S. and other Western countries must never be pushed onto Africa."

He likened the drug's distribution in Africa to the U.S. government's 40-year syphilis experiment using poor blacks in Tuskegee, Ala., after World War II.

The Associated Press reported Monday that the National Institutes of Health knew about problems with the drug, nevirapine, as early as 2002, but did not tell the White House before President Bush launched a plan that summer to distribute the drug throughout Africa.

Documents obtained by the AP show that Dr. Edmund C. Tramont, chief of the NIH's AIDS division, rewrote an NIH safety report on nevirapine to omit negative conclusions, and later ordered the research to continue over the objections of his staff.

Dr. H. Clifford Lane, the NIH's No. 2 infectious disease specialist and one of Tramont's bosses, has said an internal review cleared Tramont of scientific misconduct. He said Tramont changed the report because he was more experienced than his safety experts and had an "honest difference of opinion."


041217
AP041249


Copyright © 2004 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .